Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series

Open Access

Peer-reviewed

Research Article

Francesco Checchi,

Affiliations Epicentre, Paris, France, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
⨯
Patrice Piola,

Affiliation Epicentre, Paris, France
⨯
Harriet Ayikoru,

Affiliation Médecins Sans Frontières, French section, Paris, France
⨯
Florence Thomas,

Affiliation Epicentre, Paris, France
⨯
Dominique Legros,

Affiliations Epicentre, Paris, France, Alert and Response Operations, Epidemic and Pandemic Alert and Response, World Health Organization, Geneva, Switzerland
⨯
Gerardo Priotto

* E-mail: gerardo.priotto@epicentre.msf.org

Affiliation Epicentre, Paris, France
⨯

Reader Comments (2)

African trypanosomiasis
Is the Subject Area "African trypanosomiasis" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Bilirubin
Is the Subject Area "Bilirubin" applicable to this article?

Thanks for your feedback.
Case series
Is the Subject Area "Case series" applicable to this article?

Thanks for your feedback.
Uganda
Is the Subject Area "Uganda" applicable to this article?

Thanks for your feedback.
Cerebrospinal fluid
Is the Subject Area "Cerebrospinal fluid" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.